Marksans Pharma has informed that it enclosed a press release where in the Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).
The above information is a part of company’s filings submitted to BSE.